已收盘 10-08 16:00:00 美东时间
0.000
0.00%
Viridien, a French société anonyme with a capital of €7,180,449, headquartered in Massy, France, reported its voting rights and share information as of July 31, 2025. The total issued shares were 7,180,449, with actual voting rights at 7,213,469 and theoretical voting rights at 7,213,718. Shares held for over two years carry double voting rights, while treasury shares have no voting rights. The figures comply with French Commercial Code and AMF r...
08-01 08:23
Viridien SA published its interim financial report as of June 30, 2025, available via the AMF and accessible on its website under the Investors section. The company, specializing in advanced Earth data and technology solutions, employs around 3,400 globally and is listed on Euronext Paris ( ticker VIRI). The report highlights Viridien's contributions to natural resource, energy, and digital challenges.
07-31 17:17
Viridien will announce its Q2 2025 financial results on Thursday, July 31, after market close. The press release and presentation will be available on www.viridiengroup.com at 5:45 pm CET. An English-language conference call is scheduled at 6:00 pm CET. Register via the link to receive dial-in details or join the live webcast. A replay will be available on the company’s website for 12 months. Viridien is an advanced technology company focused on ...
07-17 05:30
<p>Viridien launched the Sercel Accel, the first onshore drop node solution, at the EAGE Annual Conference in Toulouse. This innovative system revolutionizes land seismic data acquisition by eliminating the need for burying nodes, reducing deployment time and labor costs by up to 30%, and significantly lowering HSE risks. Accel integrates the industry-leading QuietSeis® MEMS sensor and Pathfinder QC technology, ensuring high-quality data and reli...
06-03 05:30
Virios Therapeutics press release (NASDAQ:DWTX): Q1 Non-GAAP EPS of -$8.45. Cash on hand of $17.5M provides operational runway through Q1 2026. More on Virios Therapeutics Dogwood Therapeutics announc...
05-08 22:23
Virios Therapeutics press release (NASDAQ:DWTX): Q3 GAAP EPS of -$2.05. The company estimates that its current cash of $2M at Sept. 30 along with the $16.5M in loan proceeds received on Oct. 7 is not ...
2024-11-07 22:55
Dogwood Therapeutics (NASDAQ:DWTX), formerly known as Virios Therapeutics, has regained compliance with Nasdaq's minimum bid price requirement. DWTX shares were trading +0.90% Wednesday pre-market. Th...
2024-10-30 21:22
北京时间2024年10月09日01时25分,Allogene Therapeutics, Inc.(ALLO.us)股票出现波动,股价快速拉升5.00%。截至发...
2024-10-09 01:25